{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:02:31Z","timestamp":1759017751882,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","award":["CAMN107AKR11T"],"award-info":[{"award-number":["CAMN107AKR11T"]}],"id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.leukres.2021.106728","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T18:27:39Z","timestamp":1634322459000},"page":"106728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ultra-deep sequencing mutation analysis of the BCR\/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients"],"prefix":"10.1016","volume":"111","author":[{"given":"Hyunkyung","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Yeop","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Yeoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oh-Hyung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoo-Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Sook","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinny","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Kyun","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9402-6372","authenticated-orcid":false,"given":"Jeong-Ok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June-Won","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Ha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon-Gu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2036-1466","authenticated-orcid":false,"given":"Hawk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hyun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Rok","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Gon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-6341","authenticated-orcid":false,"given":"Sung Hwa","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hun Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doyeun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seonyang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.leukres.2021.106728_bib0005","doi-asserted-by":"crossref","first-page":"20810","DOI":"10.18632\/oncotarget.8021","article-title":"Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.leukres.2021.106728_bib0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12967-017-1353-y","article-title":"Next-generation sequencing: recent applications to the analysis of colorectal cancer","volume":"15","author":"Del Vecchio","year":"2017","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.leukres.2021.106728_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6100091","article-title":"Comparison of minimal residual disease detection by multiparameter flow cytometry, ASO-qPCR, droplet digital PCR, and deep sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation","volume":"6","author":"Takamatsu","year":"2017","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.leukres.2021.106728_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10408363.2017.1299683","article-title":"Using circulating cell-free DNA to monitor personalized cancer therapy","volume":"54","author":"Oellerich","year":"2017","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"2","key":"10.1016\/j.leukres.2021.106728_bib0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/cam4.61","article-title":"Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma","volume":"2","author":"Metz","year":"2013","journal-title":"Cancer Med."},{"issue":"12","key":"10.1016\/j.leukres.2021.106728_bib0030","first-page":"i9","article-title":"De novo meta-assembly of ultra-deep sequencing data","volume":"31","author":"Mirebrahim","year":"2015","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"7","key":"10.1016\/j.leukres.2021.106728_bib0035","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3324\/haematol.2016.145888","article-title":"Ultra-deep sequencing leads to earlier and more sensitive detection of the tyrosine kinase inhibitor resistance mutation T315I in chronic myeloid leukemia","volume":"101","author":"Baer","year":"2016","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.leukres.2021.106728_bib0040","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/leu.2016.286","article-title":"Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia","volume":"31","author":"Ojamies","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2021.106728_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41408-018-0062-y","article-title":"A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5","volume":"8","author":"White","year":"2018","journal-title":"Blood Cancer J."},{"issue":"93","key":"10.1016\/j.leukres.2021.106728_bib0050","doi-asserted-by":"crossref","first-page":"36613","DOI":"10.18632\/oncotarget.26400","article-title":"Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia","volume":"9","author":"Patkar","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.leukres.2021.106728_bib0055","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/leu.2016.5","article-title":"Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial","volume":"30","author":"Hochhaus","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2021.106728_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055717","article-title":"Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+ cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib resistance: implications in the post-imatinib era","volume":"8","author":"Iqbal","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1016\/j.leukres.2021.106728_bib0065","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1007\/s00277-015-2322-2","article-title":"A review of the European LeukemiaNet recommendations for the management of CML","volume":"94","author":"Baccarani","year":"2015","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.leukres.2021.106728_bib0070","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood-2010-12-326405","article-title":"BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet","volume":"118","author":"Soverini","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2021.106728_bib0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yexmp.2012.01.007","article-title":"BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naive and -exposed Southeast Asian chronic myeloid leukemia patients","volume":"92","author":"Wongboonma","year":"2012","journal-title":"Exp. Mol. Pathol."},{"issue":"18","key":"10.1016\/j.leukres.2021.106728_bib0080","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1200\/JCO.2005.05.531","volume":"23","author":"Soverini","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106728_bib0085","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","article-title":"Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis","volume":"102","author":"Branford","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2021.106728_bib0090","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/sj.leu.2404318","article-title":"Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2021.106728_bib0095","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/cam4.1450","article-title":"A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea","volume":"7","author":"Shin","year":"2018","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.leukres.2021.106728_bib0100","doi-asserted-by":"crossref","first-page":"17841","DOI":"10.1038\/s41598-017-18064-9","article-title":"Transcriptomic analysis of mitochondrial TFAM depletion changing cell morphology and proliferation","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.leukres.2021.106728_bib0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet.journal"},{"key":"10.1016\/j.leukres.2021.106728_bib0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.leukres.2021.106728_bib0115","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"issue":"5","key":"10.1016\/j.leukres.2021.106728_bib0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.leukres.2021.106728_bib0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2353\/jmoldx.2009.080095","article-title":"Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology","volume":"11","author":"Jones","year":"2009","journal-title":"J. Mol. Diagn."},{"issue":"9","key":"10.1016\/j.leukres.2021.106728_bib0130","first-page":"1108","article-title":"Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology","volume":"16","author":"Radich","year":"2018","journal-title":"J. Compr. Canc. Netw."},{"issue":"11","key":"10.1016\/j.leukres.2021.106728_bib0135","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1002\/ajh.23338","article-title":"Three novel patient-derived BCR\/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors","volume":"87","author":"Redaelli","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.leukres.2021.106728_bib0140","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/phar.1266","article-title":"Treatment-, patient-, and disease-related factors and the emergence of adverse events with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia","volume":"33","author":"Irvine","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"21","key":"10.1016\/j.leukres.2021.106728_bib0145","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1158\/1078-0432.CCR-18-0167","article-title":"Single-molecule sequencing reveals patterns of preexisting drug resistance that suggest treatment strategies in Philadelphia-Positive Leukemias","volume":"24","author":"Schmitt","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.leukres.2021.106728_bib0150","doi-asserted-by":"crossref","first-page":"lqab019","DOI":"10.1093\/nargab\/lqab019","article-title":"Sequencing error profiles of Illumina sequencing instruments","volume":"3","author":"Stoler","year":"2021","journal-title":"NAR Genomics Bioinformatics"},{"issue":"2","key":"10.1016\/j.leukres.2021.106728_bib0155","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1158\/1078-0432.CCR-13-1988","article-title":"Deep molecular response in chronic myeloid leukemia: the new goal of therapy?","volume":"20","author":"Mahon","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.leukres.2021.106728_bib0160","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00277-006-0171-8","article-title":"Not all imatinib resistance in CML are BCR-ABL kinase domain mutations","volume":"85","author":"Wei","year":"2006","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2021.106728_bib0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-8722-1-15","article-title":"P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia","volume":"1","author":"Cang","year":"2008","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106728_bib0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-018-0780-6","article-title":"Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy","volume":"17","author":"Soverini","year":"2018","journal-title":"Mol. Cancer"},{"issue":"23","key":"10.1016\/j.leukres.2021.106728_bib0175","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood.V126.23.346.346","article-title":"BCR-ABL mutations in Chronic Myeloid Leukemia (CML) Patients (pts) with failure and warning to first- and second-line Tyrosine Kinase Inhibitor (TKI) therapy: what is the advantage of next-generation sequencing (ngs) over conventional sequencing?","volume":"126","author":"Simona Soverini","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2021.106728_bib0180","doi-asserted-by":"crossref","first-page":"669","DOI":"10.5858\/2006-130-669-IROAO","article-title":"Imatinib resistance: obstacles and opportunities","volume":"130","author":"Litzow","year":"2006","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"11","key":"10.1016\/j.leukres.2021.106728_bib0185","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jnci\/90.11.850","article-title":"A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group","volume":"90","author":"Hasford","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"19","key":"10.1016\/j.leukres.2021.106728_bib0190","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1182\/blood-2011-10-388967","article-title":"EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience","volume":"119","author":"Jabbour","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2021.106728_bib0195","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \"good-risk\" chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521262101729X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521262101729X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:03:01Z","timestamp":1758934981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521262101729X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"alternative-id":["S014521262101729X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106728","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultra-deep sequencing mutation analysis of the BCR\/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106728"}}